Dr. Cirrito is a serial entrepreneur, inventor, and founder of multiple companies in the life sciences. He was the second employee at Stemline Therapeutics (NASDAQ: STML; acquired by a private company), and led all drug development and business development operations of the company. Dr. Cirrito was a co-inventor of Stemline’s brain cancer vaccine, SL-701, and led the in-licensing of Elzonris©, a biologic therapy for leukemia. Tom has a PhD in Immunology from Washington University in St. Louis.
